FDA advises consumers not to purchase adulterated ‘MAXILOSS Weight Advanced’
SILVER SPRING, Md. — The Food and Drug Administration on Tuesday advised consumers not to purchase or use “MAXILOSS Weight Advanced” — a product promoted and sold for weight loss on various web sites, including DreamLifeWeightLoss.com, and in some retail stores.
FDA laboratory analysis confirmed that “MAXILOSS Weight Advanced” contains sibutramine, a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact in life-threatening ways with other medications a consumer may be taking.
Consumers should stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a healthcare professional as soon as possible.
This notification is to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals, the FDA noted. These products are typically promoted for sexual enhancement, weight loss and body-building and are often represented as being “all natural.”
iHealth Labs launches two new Apple-compatible diagnostic devices at Consumer Electronics Show
LAS VEGAS — iHealth Labs on Monday unveiled two new additions to its suite of devices — the iHealth Wireless Smart Gluco-Monitoring System and iHealth Pulse Oximeter — at the 2013 Consumer Electronics Show here.
The next-generation Wireless Smart Gluco-Monitoring System is an International CES Best of Innovations 2013 Design and Engineering Award honoree and provides a portable system for people who regularly monitor their blood-glucose levels. For people tracking the level of oxygen in their blood for fitness or health, the Pulse Oximeter offers a quick and reliable way to measure blood oxygen saturation and pulse rate directly from a mobile device.
As with existing iHealth devices, users of these products and the companion mobile apps will be able to take full advantage of the iHealth Cloud Service to instantly store and share their results online.
"These new products are intuitive FDA-reviewed devices which empower people to easily manage critical health problems such as diabetes and heart disease, and fitness activities such as oxygen levels and pulse conditions," stated Adam Lin, general manager of iHealth Labs.
iHealth’s Wireless Smart Gluco-Monitoring System provides diabetics with a convenient way to measure and record blood-glucose levels from their mobile devices. The Wireless Smart Gluco-Monitoring System connects wirelessly to a wide range of iOS devices, including the new iPhone 5. Users can instantly save up to 500 test results on the wireless meter, track trends over time, set up reminders to take medications and track test strip expiration dates automatically without requiring counting or coding.
The iHealth Pulse Oximeter is a reliable way to easily measure blood oxygen saturation and pulse rate directly from an iOS device. Both athletes and patients with breathing conditions will find the Pulse Oximeter useful to check their status and track their progress. This lightweight and portable device connects wirelessly via Bluetooth to take fast, non-invasive measurements at the fingertip and displays results on an easy-to-read LED screen. Tracking oxygen levels over time is crucially important for athletes, along with people with breathing difficulties, heart issues or other health challenges requiring a quick view of their blood oxygen levels.
Pending Food and Drug Administration approval, these products will be available for purchase in the second half of 2013, iHealth stated. Pricing has not yet been announced.
Dollar channel expanding its promotional horizons with this strong cough, cold and flu season
COMMERCE, Calif. — Fueled by strong store growth and increased household penetration, dollar stores have been stepping outside of their comfort zone in pursuit of consumer trips that have historically belonged to retail pharmacy.
For example, 99 Cents Only Stores on Tuesday promoted its stores as the cough/cold destination of choice for consumers this season. "99 Cents Only Stores understands that many people are unable to afford expensive medicines, vitamins and sanitizers to help protect against this particularly harsh strain of the virus," the dollar operator stated. "99 Cents Only Stores provides a one-stop shopping experience for your treatment and preventive efforts against the flu. For a buck each or less, 99 Cents Only Stores carry cough and cold medicines, flu fighters, vitamins, cough drops, hand soaps and sanitizers, tissue," the chain added. "Being on a budget does not mean that you have to be under the weather this season."
Whether it’s promotions like these that are driving cough/cold consumers into the dollar channel, or the sluggish economy that has driven those consumers in search of greater values is unclear. What is clear is the dollar channel has been capturing more customers and more trips even as the drug channel loses both customers and trips.
According to Nielsen Homescan data published Friday, household penetration for dollar stores through mid-2012 stood at 66%, up from 59% in 2011. Conversely, drug channel penetration was 78%, down from 86%, for the same time periods.
"The dollar store channel, comprised of retailers like Family Dollar, Dollar General, Dollar Tree, Fred’s and 99 Cents Only, continues to expand channel shopper bases via new store openings," Nielsen noted. "These low-priced, limited assortment retailers are very entrenched among low-income households."